Zobrazeno 1 - 10
of 170
pro vyhledávání: '"L. Jardim"'
Autor:
Fernanda Capareli, Frederico Costa, Jack A. Tuszynski, Micelange C. Sousa, Yone de C. Setogute, Pablo D. Lima, Luciana Carvalho, Elizabeth Santos, Brenda P. Gumz, Jorge Sabbaga, Tiago B. deCastria, Denis L. Jardim, Daniela Freitas, Natally Horvat, Regis O. F. Bezerra, Leonardo Testagrossa, Tiago Costa, Tatiana Zanesco, Antonio F. Iemma, Ghassan K. Abou‐Alfa
Publikováno v:
Cancer Medicine, Vol 12, Iss 11, Pp 12402-12412 (2023)
Abstract Background Patients with advanced hepatocellular carcinoma (HCC) and poor liver function lack effective systemic therapies. Low‐energy electromagnetic fields (EMFs) can influence cell biological processes via non‐thermal effects and may
Externí odkaz:
https://doaj.org/article/e607313da1734bf38413f03a8853d977
Autor:
Aline B. Lara Gongora, Gustavo Werutsky, Denis L. Jardim, Angelica Nogueira-Rodrigues, Carlos H. Barrios, Clarissa Mathias, Fernando Maluf, Rachel Riechelmann, Maurício Fraga, Henry Gomes, William N. William, Camilla A. F. Yamada, Gilberto de Castro Jr, Daniela D. Rosa, Andreia C. de Melo, Raul Sala, Eva Bustamante, Denisse Bretel, Oscar Arrieta, Andrés F. Cardona, Diogo A. Bastos
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 649-658 (2021)
PURPOSECOVID-19 has affected cancer care worldwide. Clinical trials are an important alternative for the treatment of oncologic patients, especially in Latin America, where trials can be the only opportunity for some of them to access novel and, some
Externí odkaz:
https://doaj.org/article/c6436c3390d04fb48eb100f0ab3f6c2c
Autor:
Suely M. Rezende, Leticia L. Jardim, Vera Lúcia Magalhães, Helder Teixeira Melo, João Paulo B. Araujo, Guilherme Genovez
Publikováno v:
Blood Advances, Vol 3, Iss , Pp 48-50 (2019)
Externí odkaz:
https://doaj.org/article/10653697059b43dcafe039b8b7c635b1
Autor:
Denis L. Jardim, Adriano Gonçalves e Silva, Alexandre Saad Fere Lima Pompeo, Alvaro Sadek Sarkis, Ana Paula Garcia Cardoso, Andre Deeke Sasse, Andre Poisl Fay, Andrey Soares, Antonio Carlos Lima Pompeo, Arie Carneiro, Ariel Galapo Kann, Camilla Fogassa, Celso Heitor De Freitas, Daher Cezar Chade, Daniel Herchenhorn, Daniel Vargas Pivato De Almeida, Diogo Augusto Rodrigues Da Rosa, Evanius Garcia Wiermann, Fabio Augusto Barros Schutz, Fabio Roberto Kater, Fernando De Moura, Fernando Korkes, Fernando Meyer, Fernando Nunes Galvao De Oliveira, Fernando Sabino, Gilberto Laurino Almeida, Guilherme Avanço, Gustavo Cardoso Guimaraes, Gustavo Caserta Lemos, Gustavo Franco Carvalhal, Hanna Kim, Igor Protzner Morbeck, Joao Carlos Campagnari, Jose Augusto Rinck, José Ricardo Tuma Da Ponte, Karine Martins Da Trindade, Leonardo Atem, Leonardo Borges, Lucas Mendes Nogueira, Lucas Teixeira e Aguiar Batista, Manuel Caitano Maia, Marcus Vinicius Sadi, Maria Alzira Almeida Rocha, Murilo De Almeida Luz, Oren Smaletz, Paulo Sergio Moraes Lages, Raquel Midori Koga Matuda, Rodolfo Borges Dos Reis, Rodrigo Frota Indio, Roni De Carvalho Fernandes, Sandro Roberto Cavallero, Vinicius Carrera Souza, Wilson Busato, Wladimir Alfer, Fernando Maluf
Publikováno v:
Clinical Genitourinary Cancer. 21:e58-e69
Non-metastatic, castration-resistant prostate cancer (nmCRPC) is an important clinical stage of prostate cancer, prior to morbidity and mortality from clinical metastases. In particular, the introduction of novel androgen-receptor signaling inhibitor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea4e178f24a0a8e9fe8f1fdc8ed4c395
https://doi.org/10.1016/j.clgc.2022.09.005
https://doi.org/10.1016/j.clgc.2022.09.005
Autor:
Pedro Marques, Maria T. Brito, Francisco Vasques-Nóvoa, João P. Ferreira, Ana L. Jardim, Rita Gouveia, Bruno Besteiro, Joana T. Vieira, Filipa Gomes, Adelino Leite-Moreira, Paulo Bettencourt, Jorge Almeida, Fernando Friões
Publikováno v:
European Journal of Emergency Medicine. 30:85-90
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::798d3416f413ddb3aa0c982bcecf20f8
https://doi.org/10.1097/mej.0000000000001006
https://doi.org/10.1097/mej.0000000000001006
Autor:
Denis L. Jardim, Débora De Melo Gagliato, Mina Nikanjam, Donald A. Barkauskas, Razelle Kurzrock
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Hundreds of trials are being conducted to evaluate combination of newer targeted drugs as well as immunotherapy. Our aim was to compare efficacy and safety of combination versus single non-cytotoxic anticancer agents. We searched PubMed (01/01/2001 t
Externí odkaz:
https://doaj.org/article/68c8fc18a4be4f07990edc45b5242cd0
Autor:
Luciana W. Zuccherato, Silvana M. Elói-Santos, Letícia L. Jardim, Ricardo M. Camelo, Daniel G. Chaves, Renan P. Souza, Edward J. Hollox, Suely M. Rezende
Publikováno v:
Haematologica, Vol 104, Iss 11 (2019)
Externí odkaz:
https://doaj.org/article/ca74f94e76c54f39b6a33f64eae2e528
Autor:
Franciele H. Knebel, Fabiana Bettoni, Leonardo G. da Fonseca, Anamaria A. Camargo, Jorge Sabbaga, Denis L. Jardim
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: Anti-EGFR antibodies are a standard care for advanced KRAS-wild type colorectal cancers. Circulating tumor DNA (ctDNA) monitoring during therapy can detect emergence of KRAS mutant clones and early resistance to therapy.Case Presentation:
Externí odkaz:
https://doaj.org/article/a4b9c81e2f4d41679ba68db65c0e065e
Publikováno v:
Integrative Cancer Therapies, Vol 17 (2018)
Immunotherapies are becoming increasingly important in the treatment armamentarium of a variety of malignancies. Immune checkpoint inhibitors are the most representative drugs receiving regulatory approval over the past few years. In a recent study p
Externí odkaz:
https://doaj.org/article/f7921411ed4f48328104cb2539a568ee
Includes supplementary tables referred on main text and additional references
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::844db0cc11744fe4104ebe61b91eaa48
https://doi.org/10.1158/1078-0432.22465340
https://doi.org/10.1158/1078-0432.22465340
